XBI

SPDR S&P BIOTECH ETF · PSE

  • Category Health Care
  • Expense Ratio 0.35%
  • Listing Date
  • Volume 14,041,830.0
  • Market Cap (AUM) $4,829.21M

Performance

+1.44%

1W

-10.88%

1M

-14.21%

3M

-20.89%

6M

-13.79%

YTD

-7.16%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Novavax, Inc.NVAX2.80%
  • Insmed IncorporatedINSM2.61%
  • Twist Bioscience Corp.TWST1.49%
  • Moderna, Inc.MRNA1.43%
  • United Therapeutics CorporationUTHR1.39%
  • Dyne Therapeutics IncDYN1.38%
  • Natera, Inc.NTRA1.34%
  • Halozyme Therapeutics, Inc.HALO1.33%
  • Geron CorporationGERN1.31%
  • Revolution Medicines, Inc.RVMD1.30%

Technical Analysis of XBI 2025-04-22

The stock indicators present a mixed sentiment, with the Moving Average Score at 33 indicating a bearish outlook, while the Oscillators Score at 62 suggests bullish momentum. Overall, the Technical Score of 47 reflects a neutral stance, indicating that while there are some positive signals, the overall market sentiment remains cautious.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.